PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE- AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66724-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66724-1/fulltext
Title : PG110 ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE- AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66724-1&doi=10.1016/S1098-3015(10)66724-1
First page :
Section Title :
Open access? : No
Section Order : 560
Categories :
Tags :
Regions :
ViH Article Tags :